The competition between Eli Lilly and Novo Nordisk dominates headlines, but behind them a wave of challengers, from Amgen to upstart biotechs, are probing new mechanisms and formulations
Immunology (2012) 135(1):18
It requires a habit-based nutrition protocol and a prescription for a GLP-1 peptide, that is taken once per week as a self administered at home very small subcutaneous injection
This may lead to decreased hunger, slower digestion, and better glucose control, all of which can help you achieve your weight-loss goalsno restrictive diet or extreme exercise regimen needed
Accordingly, the American Diabetes Association recommends the use of GLP-1RAs with or without metformin in patients with atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD), and/or heart failure (HF) [25]